Start a New Search
SHOWING 182 RESULTS
An effort at Stanford University to thwart viral diseases like hepatitis or the common cold led to a new collaboration and a novel class of cancer drugs that appears effective in mice.
University Research | Stanford UniversityUsing in-game win probability techniques, Stanford University researchers devised a way to better predict a cancer patient’s outcome at any point during treatment. The approach could also inform treatment decisions.
University Research | Stanford UniversityIn the largest study of its kind to date, Stanford University researchers have shown that women related to a patient with a breast cancer caused by a hereditary mutation — but who don’t have the mutation themselves — have no higher risk of getting cancer than relatives of patients with other types…
University Research | Stanford UniversityAnthracyclines can be effective against breast cancer but often have toxic side effects. Stanford researchers used gene expression levels to identify women most likely to benefit from the drugs, regardless of breast cancer type or stage.
University Research | Stanford UniversityResearchers at Stanford University found that by testing for fragments of cancer DNA in urine, they could find the cancer in early stages of development, when it’s easier to treat.
University Research | Stanford UniversitySome breast cancers return decades later. Now, a researcher at Stanford University, joined by collaborators at several other institutions, has subcategorized tumors to predict recurrence, guide treatment decisions and improve drug development.
University Research | Stanford UniversityA large study of women with breast and ovarian cancer has revealed significant gaps between national guidelines for genetic testing and actual testing practices, according to researchers from Stanford and five other institutions.
University Research | Stanford University | University of Southern CaliforniaUp to 80% of metastatic colorectal cancers are likely to have spread to distant locations in the body before the original tumor has exceeded the size of a poppy seed, according to a study of nearly 3,000 patients by researchers at the Stanford University School of Medicine.
University Research | Stanford University | University of Southern CaliforniaStanford University scientists were able to engineer immune cells known as macrophages to detect and flag cancer in mice. The researchers hope the technique can be used for early cancer diagnostics in humans.
University Research | Stanford UniversitySynthetic proteins engineered to recognize overly active biological pathways can kill cancer cells while sparing their healthy peers, according to a study by researchers at the Stanford University School of Medicine.
University Research | Stanford University